Skip to content

LD-Oncologic

Active Private limited companyfounded 2013active for 13 yearsRue des Ecoles 7, 5520 OnhayeKBO/BCE: BE 0533.702.512

Annual accounts 2025

micro format, filed on 15-07-2026, 16 days before the deadline
€69,307
▲ 11.0%
€62,191
▲ 12.5%
€67,699
▲ 15.3%
€45,132
▲ 18.2%
52.3%
▲ 5.8 percentage points
3.57
▲ 0.01

Money flows

no detail for 2025

Balance sheet

balance sheet total €268,450 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420138 months
67,69958,71318,07440,06747,41955,81645,16465,69257,91951,73459,476-54,82948,955
45,13238,17713,27632,05337,17646,46037,26853,65952,60845,74452,101-61,10239,687
17,314143,06402,279000046,372-003,919232,210
23,582-2,019-9,5271,0829,55111,696-1,873-26-167171-2,7742,492-
84,47475,45777,12163,84651,11738,91920,70411,8947,30919,83816,416-1,9665,449
--6.9%10.9%---------
52.3%46.5%84.6%72.5%52.6%34.3%19.3%11.9%-0.4%-10.4%-16.5%-23.3%10.8%
3.573.566.373.372.412.021.481.201.131.401.310.971.09
0.911.150.180.380.901.914.197.39----8.29
28.2%30.6%9.8%16.8%29.1%35.5%21.0%103.3%----58.8%
14.8%14.2%8.3%12.2%15.3%12.2%4.0%12.3%9.7%8.5%10.2%-34.9%6.3%
10.469.2425.8630.9024.69--------
--16 days11 days---------
--26 days19 days---------

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420138 months
Balance sheet: assets
20/58 268,450244,24593,06797,894112,348122,036140,198179,115203,574196,884226,455259,503279,710
20 ------------311
21/28 151,100139,2941,5927,16225,00045,00076,593108,186139,779127,987156,994186,014211,463
21 --05,00025,00045,00065,00085,000105,000125,000145,000165,000185,000
22/27 151,100139,2941,5922,162--11,59323,18634,7792,98711,99421,01426,152
22 150,647138,271-----------
23 -----------1363
24 4531,0221,5922,162--11,59323,18634,7792,98711,99421,00126,089
29/58 117,351104,95191,47590,73387,34877,03663,60570,92963,79568,89869,46173,48968,247
40/41 81417,1908,0595,3454,0814,3504,3133,0551,987528---
41 81417,1908,0595,3454,0814,3504,3133,0551,987528---
54/58 39,47515,89317,91227,43926,35716,8055,1106,9827,0097,1757,0049,7787,285
490/1 77,06271,86865,50457,94956,91055,88154,18360,89254,79961,19462,45763,71260,962
Balance sheet: equity and liabilities
10/49 268,450244,24593,06797,894112,348122,036140,198179,115203,574196,884226,455259,503279,710
10/15 140,314113,45978,71371,00759,07241,89527,02821,353-714-20,555-37,292-60,37330,097
10/11 12,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,40012,400
100 ------18,60018,60018,60018,60018,60018,60018,600
101 ------6,2006,2006,2006,2006,2006,2006,200
13 127,914101,05966,31358,60746,67229,49514,6288,9531,8601,8601,8601,8601,860
130/1 1,8601,8601,8601,8601,8601,860-------
130 ------1,8601,8601,8601,8601,8601,8601,860
1311 1,8601,8601,8601,8601,8601,860-------
133 126,05499,19964,45356,74744,81227,63512,7687,093-----
14 ---------14,974-34,815-51,552-74,63315,837
17/49 128,136130,78614,35426,88753,27680,141113,170157,763204,288217,440263,747319,876249,613
17 95,241101,292-017,04542,02370,26998,728147,801168,380210,694244,397186,815
170/4 95,241101,292-017,04542,02370,26998,728147,801168,380210,694244,397186,815
42/48 32,87729,49414,35426,88736,23138,11742,90159,03556,48649,05953,04575,45662,798
42 6,0505,853-17,04524,97828,24629,00949,07449,80642,31444,51644,28023,682
44 4,3727,83213,5838,6487,9318,3855,5226,2456,5274,6695,7996,8447,110
440/4 4,3727,83213,5838,6487,9318,3855,5226,2456,5274,6695,7996,8447,110
45 6,3975,1717711,1943,3221,4878,3703,7171542,0771,9767,3847,247
450/3 6,3975,1717711,1943,3221,4878,3703,7171542,0771,9767,3847,247
47/48 16,05710,638--------75416,94724,758
492/3 17---------823-
Income statement
70 --181,408183,758---------
76A --6,000----------
9900 69,30762,46023,70741,00548,51056,50845,94166,78159,44452,49660,228-54,07850,580
60/61 --193,312169,869---------
630 5,5083,4315,57020,11720,00031,59331,59331,59332,76729,00729,02029,36821,990
640/8 1,6071,8155,6339371,0916927771,0881,5257617527501,625
66A 01,931-----------
9901 62,19155,28212,50419,95027,41924,22313,57234,09925,15222,72730,456-84,19726,965
75/76B 59------------
75 59------------
65/66B 6,4756,3516991,2971,9212,5743,2424,3165,1585,8667,2536,0972,020
65 6,4756,3516991,2971,9212,5743,2424,3165,1585,8667,2536,0972,020
9903 55,77548,93111,80518,65425,49821,65010,32929,78319,99316,86123,203-90,29324,945
67/77 16,15214,1864,0996,7188,3226,7824,6537,7171521241221777,247
9904 39,62334,7467,70611,93617,17614,8675,67622,06719,84116,73723,081-90,47017,697
9905 39,62334,7467,70611,93617,17614,8675,67622,06719,84116,73723,081-90,47017,697
Appropriation of the result
9906 39,62334,7467,70611,93617,17614,8675,6767,093-14,974-34,815-51,552-74,63317,697
791/2 12,768------------
691/2 52,39134,7467,70611,93617,17614,8675,6767,093----1,860
6920 ------------1,860
6921 52,39134,7467,70611,93617,17614,8675,6767,093-----
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 15-07-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 15-07-2026 2026-00312733 PDF
31-12-2024 micro format 20-08-2025 2025-00384849 PDF
31-12-2023 micro format 30-08-2024 2024-00418874 PDF
31-12-2022 micro format 29-08-2023 2023-00430390 PDF
31-12-2021 micro format 25-08-2022 2022-20323753 PDF
31-12-2020 micro format 26-08-2021 2021-55000181 PDF
31-12-2019 micro format 14-07-2020 2020-29600306 PDF
31-12-2018 micro format 11-07-2019 2019-31900350 PDF
31-12-2017 micro format 03-07-2018 2018-28500476 PDF
31-12-2016 micro format 28-07-2017 2017-39100179 PDF
31-12-2015 full format 15-07-2016 2016-32200127 PDF
31-12-2014 full format 31-07-2015 2015-38300586 PDF
31-12-2013 full format 28-08-2014 2014-53200034 PDF

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€17,314€143,064-€2,279-
Financial fixed assets€0----
€5,508€3,431€5,570€20,117€20,000

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on LD-Oncologic

The operating result for 2025 is 12% higher than in 2024 and the highest since 2014. It is the second rise in a row, after the fall in 2023.

Debt's share of the balance-sheet total falls from 53.5% to 47.7%. Equity is higher and debt is lower.

Next steps